After anti-PD-1 therapy, we observed increased abundance of T cells co-expressing CLA, a molecule facilitating skin homing,12 and CD39, an ectoenzyme upregulated on tumor-specific T cells.14 The gene discussed is ENTPD1; the disease is neoplasm.